A 32-kilodalton protein antigen (P32) was previously purified to homogeneity from culture ifitrate of Mycobacterium bovis BCG (J. De Bruyn, K. Huygen, R. Bosmans, M. Fauville, R. Lippens, J. P. Van Vooren, P. Falmagne, H. G. Wiker, M. Harboe, and M. Turneer, Microb. Pathog. 2:351-366, 1987). Spleen cells from BCG-sensitized mice produce significant amounts of gamma interferon (IFN-,y) in response to this P32 protein.
producing low titers in response to the P32 antigen.
Interferons (IFN) are a group of antiviral proteins and glycoproteins induced in nucleated cells by numerous inducers such as viruses, synthetic polyribonucleotides, T-cell mitogens, and various microbial antigens (3, 28) . In mice, the amount of IFN produced is controlled by the genotype, with C57BL/6 mice producing 5 to 10 times more IFN than BALB/c mice during a number of viral (9, 33) , bacterial (11, 18) , or protozoal (8, 23) infections. The regulatory genes causing this strain variation are completely unknown at present, but they appear to be different for each inducer examined.
In Mycobacterium bovis BCG-primed animals, low IFN--y levels in BALB/c spleen cell cultures stimulated with tuberculin are apparently not caused by suppressor macrophages or suppressor T cells or by inactivation of secreted IFN (11) . More probably, the low levels are due to direct differences in transcription at the mRNA level, as reported by Sadick et al. in another experimental model, i.e., murine cutaneous leishmaniasis (23) .
In all prior studies on IFN-y production in BCG-primed mice, purified protein derivative (PPD) has been used as the inducing antigen. Because PPD is a complex and varying mixture of several mycobacterial antigens, its use in the study of genetic variation of IFN production is obviously limited. We have recently reported on the purification of a 32-kilodalton protein (P32) from M. bovis BCG culture filtrate (7) . P32 was identified as antigen 85A in the Closs reference system for mycobacteria; the antigen 85 complex is found exclusively in mycobacteria (4, 10) . P32 is the first and major protein detectable in Sauton culture filtrate of actively growing BCG cultures and is also a well-represented component of BCG cells. Furthermore, P32 epitopes are present in PPD preparations (7) . P32 antigen induces significant IFN--y production in spleen cells from BCG-primed mice (7) and in peripheral blood leukocytes from tuberculous patients and healthy PPD skin test-positive controls (15 Here we show that the amount of IFN--y produced in vitro by BCG-primed spleen cells challenged with P32 antigen is under genetic control, with C57BL/6 mice producing about four times more IFN-y than BALB/c mice. Furthermore, we demonstrate a probable H-2-linked control of this variation in IFN--y production.
MATERIALS AND METHODS
Mice. BALB/c, C57BL/6, CBF1, DBA/2, and BALB/c x C57BL/6 cross (C x B) line D, E, G, H, I, J, and K mice were bred in the animal facilities at the Pasteur Institute of Brabant, Brussels, Belgium. C57BL/1OScSnA and congenic BALB. B10/LiA (H-2b) and B10.D2/nSnA (H-2d) mice (17) were bred at the Netherlands Cancer Institute, Amsterdam. 129/Sv mice were obtained from J. Van stomatitis virus dilution at a multiplicity of infection of 1. The log2 titer was determined as the last dilution in which 50% of L929 cells were protected against the cytopathic effect of vesicular stomatitis virus. One log2 unit corresponds to 6 IU (GgO2-901-533 NIH, Bethesda, Md.).
Elimination of L3T4+ cells. Spleen cells were incubated for 2 h at 4°C in culture supernatant from the GK 1.5 hybridoma line, which produces anti-L3T4 antibodies (32) . Cells were then treated with 5% fresh guinea pig complement at 37°C for 1.5 h, washed once in RPMI 1640 medium, and suspended to 3 x 10' cells per ml for culture.
RESULTS
Genotype variation in PPD-and P32-induced IFN-y. The amount of IFN--y produced by BCG-primed spleen cells in response to both PPD and P32 depended on the mouse strain ( Fig. 1) . BALB/c spleen cells produced about four times less IFN than C57BL/6 spleen cells. CBF1 cells produced low IFN titers. Significant IFN levels were already obtained after 24 h of cultut -, and peak IFN levels were observed between 48 and 72 h. Genotype-linked differences were seen throughout the 4-day culture period and over a range of P32 concentrations from 1 to 50 ,ug/ml. At the lowest antigen concentrations, IFN levels were almost undetectable in low-responder mice. We therefore chose the dose of 25 ,ug/ ml for further genetic studies, as it consistently induced IFN in all strain combinations. cells, as has been previously reported (22) .
Characterization of P32-induced IFN. As reported previously (7), P32-induced antiviral activity could be completely neutralized by a polyclonal rabbit antibody directed against Escherichia coli-derived murine IFN--y, indicating its genuine IFN--y character. Control mice not sensitized with BCG produced no IFN in response to PPD or P32 ( (15) .
Furthermore, C57BL/6 splenocytes produced about four times more IFN--y in response to P32 than BALB/c cells did. As we have previously reported, BCG-primed C57BL/6 cells produce more IFN--y in response to PPD than BALB/c cells do (12) . Studies on F1, F2, and backcross generation mice have indicated that one major autosomal locus is involved in the control of this PPD-induced IFN-y activity, though the influence of additional minor loci could not be excluded (13) . Further genetic analysis of the BCG-PPD IFN response turned out to be more difficult than expected at first. Studies on the seven RI lines derived from the BALB/c x C57BL/6 cross never revealed a clear-cut SDP (14; this report).
Using the P32 protein as the antigenic IFN--y inducer, we could establish a clear SDP for the same seven RI lines: D and H were classified as BALB/c-type low responders, whereas the other five lines, i.e., E, G, I, J, and K, produced high levels of P32-induced IFN, comparable to C57BL/6 values. This response paralleled the pattern observed for PPD-induced IFN in four of seven RI lines. The SDP observed for P32-induced IFN followed the SDP described for the H-2 locus (29) : all H-2b haplotypes corresponded to high producers, and all H-2d haplotypes corresponded to low producers. Congenic pairs differing only at a chromosome 17 fragment containing the MHC locus were therefore studied, and they confirmed the H-2-linked control of P32-induced IFN, with BALB.B10 (H-2b) mice producing high IFN To our knowledge, this is the first description of a regulatory gene involved in antigenically induced IFN--y production. In this respect it is interesting to note that susceptibility to mycobacterial infections and the immune reactions they evoke have been correlated to certain H-2 and human leukocyte antigen (HLA) haplotypes. In mice, the H-2-linked gene(s) is known to control both granulomatous response to and host replication restriction of Mycobacterium lepraemurium (5) . Moreover, Ivanyi and Sharp have recently demonstrated that murine antibody responses to defined mycobacterial protein epitopes are also under the control of H-2 genes (16).
Control by H-2 genes may be operating at the level of antigen presentation by macrophages to T cells, but obviously, more work is needed to prove that H-2b mice indeed produce more P32-induced IFN--y than H-2d mice do as a result of a more immunodominant presentation of the relevant P32 epitopes on the H-2b macrophage.
For humans, HLA DR2-associated susceptibility to pulmonary tuberculosis has already been described (25) , and in cases of leprosy, HLA-linked genes seem to control not susceptibility per se but the leprosy type. Thus, HLA DR3 is preferentially inherited by children with polar tuberculoid leprosy, whereas HLA MT1 is observed preferentially in children with lepromatous leprosy (31) . Interestingly, lepromatous leprosy patients demonstrate low cellular immunity, as indicated by negative skin tests and low or absent lymphocyte proliferation and IFN--y production in response to Mycobacterium leprae antigens (19) .
Other genes have been implicated in protection against mycobacterial infections. In mice, the bcg gene located on chromosome 1 is known to affect early bacterial multiplication (26) , and macrophages expressing he Bcgr allele have a higher intracellular bactericidal potential than Bcgs macrophages do (27) . Whereas allelic differences in beg genes reflect differences in innate susceptibility, variability at the H-2 locus is more likely to interfere with the later stages of infection when acquired immunity plays the preponderant role. This has indeed been observed in the case of the protozoal infection caused by Leishmania donovani; innate susceptibility is under the control of the autosomal Ish gene on chromosome 1 (2), a gene which is probably identical to the above-mentioned beg gene (26) and also to the ity gene involved in resistance to Salmonella typhimurium (21) . The recovery pattern, on the other hand, of Lshs animals appears to be controlled by a gene(s) within or closely adjacent to the H-2 complex (1).
As stated by Orme (20) , it is still a matter of debate whether antigens relevant to vaccine development are to be looked for among constitutive proteins of mycobacteria or, instead, among secreted proteins produced only by living metabolizing organisms (as is the case for P32). Furthermore, a mycobacter:al infection will expose the organism to a number of antigens, but not all of them will trigger a good IFN-y response. Thus, the 64-kilodalton protein antigen of M. bovis BCG (6), known to be very immunodominant at the B-cell level, appears to be a less potent IFN--y inducer than the 32-kilodalton protein (K. Huygen, manuscript in preparation).
Clearly, much work remains to be done to define the role 
